scispace - formally typeset
C

Charles H. Hennekens

Researcher at Florida Atlantic University

Publications -  114
Citations -  14751

Charles H. Hennekens is an academic researcher from Florida Atlantic University. The author has contributed to research in topics: Aspirin & Myocardial infarction. The author has an hindex of 43, co-authored 114 publications receiving 14308 citations. Previous affiliations of Charles H. Hennekens include Mount Sinai Hospital & University of Miami.

Papers
More filters
Journal ArticleDOI

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

TL;DR: This large, primary-prevention trial among women showed that aspirin significantly reduced the risk of major cardiovascular events, ischemic stroke, and myocardial infarction among women 65 years of age or older.
Journal ArticleDOI

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

TL;DR: In this paper, the authors examined the relation between cardiovascular disease and postmenopausal hormone therapy during up to 16 years of follow-up in 59,337 women from the Nurses' Health Study, who were 30 to 55 years of age at base line.
Journal ArticleDOI

Postmenopausal hormone therapy and mortality.

TL;DR: The relation between the use of postmenopausal hormones and mortality among participants in the Nurses' Health Study, who were 30 to 55 years of age at base line in 1976, was examined.
Journal ArticleDOI

Schizophrenia and increased risks of cardiovascular disease.

TL;DR: The chief cause of excess premature mortality among patients with schizophrenia is CHD, caused mainly by their adverse risk factor profile, which is cigarette smoking, obesity leading to dyslipidemia, insulin resistance and diabetes, and hypertension.
Journal ArticleDOI

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range.

TL;DR: Higher levels of body weight within the "normal" range, as well as modest weight gains after 18 years of age, appear to increase risks of coronary heart disease (CHD) in middle-aged women.